Cambridge Cognition wins £2.2 million neurodegenerative disease trial contract
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £2.2 million contract providing cognitive assessments and electronic diaries for